COVAXX and Maersk Enter Partnership to Supply COVID-19 Vaccines Globally
- Written by Newsfile
Hauppauge, New York--(Newsfile Corp. - October 22, 2020) - COVAXX, a U.S. company developing a synthetic multitope peptide-based vaccine to fight COVID-19, today announced a global logistics partnership with Maersk, one of the world's largest shipping and integrated logistics providers. The agreement lays out a framework for all...
Read more: COVAXX and Maersk Enter Partnership to Supply COVID-19 Vaccines Globally